"CSC Pharma", UAB Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo dataFinancial statement report
Price: €9.90
Premium users: 1.00 credit
Premium users: 1.00 credit
Indicator |
---|
Turnover (€) |
Sales per employee (€) |
Profit before tax (€) |
Net Profit (€) |
Profit per employee (€) |
Total profitability (%) |
Net profitability (%) |
Equity (€) |
Amounts Payable And Liabilities (€) |
Non-current Assets (€) |
CurrentAssets (€) |
Working capital requirement |
Debt-to-equity ratio |
EBITDA margin (%) |
EBITDA (€) |
EBIT margin (%) |
EBIT (€) |
2022 |
---|
2,209,005 |
226,101 |
14,731 |
6,044 |
619 |
28.78 |
0.27 |
31,809 |
514,496 |
5,041 |
545,609 |
2023 |
---|
2,393,920 |
226,482 |
25,378 |
13,459 |
1,273 |
27.44 |
0.56 |
45,267 |
531,414 |
5,701 |
580,258 |
2024 |
---|
2,371,791 |
221,249 |
16,918 |
8,576 |
800 |
22.29 |
0.36 |
53,843 |
503,355 |
3,406 |
549,293 |
Register and
explore Okredo dataRegister and
explore Okredo data2024
Turnover (€)
2,371,791 €-1 % *
Sales per employee (€)
221,249 €-2 % *
Profit before tax (€)
16,918 €-33 % *
Net Profit (€)
8,576 €-36 % *
Profit per employee (€)
800 €-37 % *
Total profitability (%)
22.29 %-18.77 % *
Net profitability (%)
0.36 %-35.71 % *
Equity (€)
53,843 €19 % *
Amounts Payable And Liabilities (€)
503,355 €-5 % *
Non-current Assets (€)
3,406 €-40 % *
CurrentAssets (€)
549,293 €-5 % *